Literature DB >> 17505132

Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.

Baijun Fang1, Yongping Song, Jie Ma, Robert C Zhao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17505132     DOI： 10.1159/000102604

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  7 in total

Review 1.  The future of proteasome inhibitors in relapsed/refractory multiple myeloma.

Authors:  Robert Z Orlowski
Journal:  Oncology (Williston Park)       Date:  2011-11-15       Impact factor: 2.990

2.  Life-threatening dermatologic adverse events in oncology.

Authors:  Alyx C Rosen; Yevgeniy Balagula; Dennis W Raisch; Vishvas Garg; Beatrice Nardone; Nicole Larsen; Jennifer Sorrell; Dennis P West; Milan J Anadkat; Mario E Lacouture
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

3.  Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone.

Authors:  A Siniscalchi; A Tendas; L Morino; T Dentamaro; A De Bellis; A Perrotti; P de Fabritiis; P Musto; T Caravita
Journal:  Support Care Cancer       Date:  2012-05-05       Impact factor: 3.603

Review 4.  Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.

Authors:  Chau Yee Ng; Chun-Bing Chen; Ming-Ying Wu; Jennifer Wu; Chih-Hsun Yang; Rosaline Chung-Yee Hui; Ya-Ching Chang; Chun-Wei Lu
Journal:  J Immunol Res       Date:  2018-01-17       Impact factor: 4.818

Review 5.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

6.  Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy.

Authors:  Cristina Scavone; Cristina Di Mauro; Rosanna Ruggiero; Francesca Futura Bernardi; Ugo Trama; Maria Luisa Aiezza; Concetta Rafaniello; Annalisa Capuano
Journal:  Drugs Real World Outcomes       Date:  2020-03

7.  A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test.

Authors:  Gil-Soon Choi; Ho Sup Lee; Hee-Kyoo Kim
Journal:  Asia Pac Allergy       Date:  2021-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.